AU469986B2 - Sulfobenzylpenicillin salts - Google Patents

Sulfobenzylpenicillin salts

Info

Publication number
AU469986B2
AU469986B2 AU57600/73A AU5760073A AU469986B2 AU 469986 B2 AU469986 B2 AU 469986B2 AU 57600/73 A AU57600/73 A AU 57600/73A AU 5760073 A AU5760073 A AU 5760073A AU 469986 B2 AU469986 B2 AU 469986B2
Authority
AU
Australia
Prior art keywords
sulfobenzylpenicillin
salts
sulfobenzylpenicillin salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU57600/73A
Other languages
English (en)
Other versions
AU5760073A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU5760073A publication Critical patent/AU5760073A/en
Application granted granted Critical
Publication of AU469986B2 publication Critical patent/AU469986B2/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU57600/73A 1972-07-01 1973-07-02 Sulfobenzylpenicillin salts Expired AU469986B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JPJP66301/72 1972-07-01
JP6630172A JPS5512435B2 (index.php) 1972-07-01 1972-07-01

Publications (2)

Publication Number Publication Date
AU5760073A AU5760073A (en) 1975-01-09
AU469986B2 true AU469986B2 (en) 1976-02-26

Family

ID=13311838

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57600/73A Expired AU469986B2 (en) 1972-07-01 1973-07-02 Sulfobenzylpenicillin salts

Country Status (15)

Country Link
US (1) US3925357A (index.php)
JP (1) JPS5512435B2 (index.php)
AT (1) AT325206B (index.php)
AU (1) AU469986B2 (index.php)
BE (1) BE801588A (index.php)
CA (1) CA996548A (index.php)
CH (1) CH573435A5 (index.php)
CS (1) CS168036B2 (index.php)
DE (1) DE2332840A1 (index.php)
FR (1) FR2190414B1 (index.php)
GB (1) GB1386566A (index.php)
HU (1) HU166029B (index.php)
NL (1) NL7308048A (index.php)
PL (1) PL92969B1 (index.php)
SE (1) SE402916B (index.php)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522148U (index.php) * 1978-07-29 1980-02-13
DE50209483D1 (de) * 2001-02-24 2007-03-29 Boehringer Ingelheim Pharma Xanthinderivate, deren herstellung und deren verwendung als arzneimittel
US20030171424A1 (en) * 2002-03-07 2003-09-11 Lin Ai J. Intravenous formulation of artelinic acid for treatment of severe and complicated malaria
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
NZ600394A (en) * 2006-05-04 2014-04-30 Boehringer Ingelheim Int Polymorphs of a dpp-iv enzyme inhibitor
NZ600126A (en) * 2007-08-17 2013-12-20 Boehringer Ingelheim Int Purine derivatives for use in the treatment of fap-related diseases
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
BRPI0917675A2 (pt) * 2008-08-15 2015-12-01 Boehringer Ingelheim Int compostos orgânicos para cura de ferida
WO2010029089A2 (en) 2008-09-10 2010-03-18 Boehringer Ingelheim International Gmbh Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
KR20110103968A (ko) 2008-12-23 2011-09-21 베링거 인겔하임 인터내셔날 게엠베하 유기 화합물의 염 형태
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
KR20190071840A (ko) 2009-11-27 2019-06-24 베링거 인겔하임 인터내셔날 게엠베하 리나글립틴과 같은 dpp-iv 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
PH12012502162A1 (en) 2010-05-05 2013-02-04 Boehringer Ingelheim Int Combination therapy
EP2585101A1 (en) 2010-06-24 2013-05-01 Boehringer Ingelheim International GmbH Diabetes therapy
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
EP3517539B1 (en) 2011-07-15 2022-12-14 Boehringer Ingelheim International GmbH Substituted dimeric quinazoline derivative, its preparation and its use in pharmaceutical compositions for the treatment of type i and ii diabetes
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
WO2013171167A1 (en) 2012-05-14 2013-11-21 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
EP2849754B1 (en) 2012-05-14 2022-09-14 Boehringer Ingelheim International GmbH Linagliptin, a xanthine derivative as dpp-4 inhibitor, for use in the treatment of sirs and/or sepsis
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
US9526728B2 (en) 2014-02-28 2016-12-27 Boehringer Ingelheim International Gmbh Medical use of a DPP-4 inhibitor
KR102391564B1 (ko) 2016-06-10 2022-04-29 베링거 인겔하임 인터내셔날 게엠베하 리나글립틴 및 메트포르민의 병용물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1026793A (fr) * 1949-08-02 1953-05-04 American Cyanamid Co Procédé de préparation de sels de pénicilline
NL6803062A (index.php) * 1967-03-10 1968-09-11
US3557094A (en) * 1968-01-05 1971-01-19 Pfizer & Co C Substituted alkyl esters of alpha-carboxy aryl penicillins
AT290728B (de) * 1968-09-28 1971-05-15 Takeda Chemical Industries Ltd Verfahren zur herstellung neuer penicilline

Also Published As

Publication number Publication date
FR2190414A1 (index.php) 1974-02-01
PL92969B1 (index.php) 1977-04-30
AT325206B (de) 1975-10-10
DE2332840A1 (de) 1974-01-17
SE402916B (sv) 1978-07-24
AU5760073A (en) 1975-01-09
GB1386566A (en) 1975-03-12
US3925357A (en) 1975-12-09
HU166029B (index.php) 1974-12-28
CS168036B2 (index.php) 1976-05-28
JPS5512435B2 (index.php) 1980-04-02
FR2190414B1 (index.php) 1976-07-02
BE801588A (fr) 1973-12-28
CA996548A (en) 1976-09-07
JPS4925121A (index.php) 1974-03-06
NL7308048A (index.php) 1974-01-03
CH573435A5 (index.php) 1976-03-15

Similar Documents

Publication Publication Date Title
AU469986B2 (en) Sulfobenzylpenicillin salts
AU454372B2 (en) Childsafe actuator-overcap
AU470375B2 (en) Substituted w-pentanorprostaglandins
AU469305B2 (en) Deipenylyl-alkanoylaminopyridine
AU5996573A (en) Pyridinium salts
CA980352A (en) Substituted aminohalopyridines
CA950831A (en) Biocidal salts
CA995666A (en) 1-amino-pyridinium salts
CA991638A (en) Substituted 3-cyanobenzenesulfonamides
CA1010049A (en) N-acyl-o-hydrocarbylphosphoroamidothioate salts
AU5517973A (en) Cycloalkyllactamimides
AU472956B2 (en) Substituted benzodioxoles
CA1021333A (en) Triazolo-benzodiazepines
CA995680A (en) Substituted 2-benzoyloxazolidines
CA1016543A (en) Indolylimidoylheterocyclics
AU5342873A (en) Pyronorifamycins
CA893696A (en) Amcyclodin salts
CA907019A (en) N-tritylimidazolium salts
CA913109A (en) Thienyliodonium salts
AU491554B1 (en) Pyridinium salts
CA1019748A (en) Isothiocyanobenzoxazoles
CA893722A (en) Substituted hydro-2-naphthalenones
CA905407A (en) Substituted 3-aminoindazoles
CA893124A (en) Substituted 2-azabicycloalkanes
CA904319A (en) Substituted benzthiazole-n-oxides